Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The EBITDA margin is N/A as of Tuesday, October 6, 2026.
EBITDA MARGIN
N/A
Market Cap
$135.62M
EBITDA Margin
5.24%
TTM Avg
5.41%
3Y Avg
5.74%
5Y Avg
10.79%
Market Cap
$133.75M
EBITDA Margin
-27.14%
TTM Avg
-20.66%
3Y Avg
-62.77%
5Y Avg
-50.13%
Market Cap
$133.38M
EBITDA Margin
4.63%
TTM Avg
-2.31%
3Y Avg
-16.32%
5Y Avg
-24.77%
Market Cap
$136.50M
EBITDA Margin
-410.84%
TTM Avg
-410.84%
3Y Avg
-410.84%
5Y Avg
-410.84%
Market Cap
$133.05M
EBITDA Margin
-576.63%
TTM Avg
-556.12%
3Y Avg
-556.12%
5Y Avg
-556.12%
Market Cap
$137.11M
EBITDA Margin
-5.26%
TTM Avg
-11.06%
3Y Avg
-22.91%
5Y Avg
-20.50%
Market Cap
$139.42M
EBITDA Margin
-221.15%
TTM Avg
-221.15%
3Y Avg
-221.15%
5Y Avg
-221.15%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Freenome, Inc. (FRNM) | $134.87M | N/A | N/A | N/A | N/A |
| AirSculpt Technologies, Inc. (AIRS)vs › | $135.62M | 5.24% | 5.41% | 5.74% | 10.79% |
| LifeMD, Inc. (LFMD)vs › | $134.21M | -0.19% | -1.66% | -11.02% | -42.72% |
| Organigram Global Inc. (OGI)vs › | $133.75M | -27.14% | -20.66% | -62.77% | -50.13% |
| Health Catalyst, Inc. (HCAT)vs › | $133.38M | 4.63% | -2.31% | -16.32% | -24.77% |
| Atrium Therapeutics, Inc. (RNA)vs › | $136.50M | -410.84% | -410.84% | -410.84% | -410.84% |
| Pyxis Oncology, Inc. (PYXS)vs › | $133.05M | -576.63% | -556.12% | -556.12% | -556.12% |
| KORU Medical Systems, Inc. (KRMD)vs › | $137.11M | -5.26% | -11.06% | -22.91% | -20.50% |
| Alpha Cognition Inc (ACOG)vs › | $139.42M | -221.15% | -221.15% | -221.15% | -221.15% |
| Fortress Biotech, Inc. (FBIOP)vs › | $139.73M | -103.63% | -143.63% | -176.25% | -194.05% |
Gross Margin
N/A
EBITDA Margin
N/A
Operating Margin
N/A
Net Margin
N/A
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
